MedPath

Effects of Zinc supplementation on diabetes preventio

Not Applicable
Conditions
Type 2 Diabetes Mellitus
Registration Number
SLCTR/2012/010
Lead Sponsor
ational Science Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow up complete
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

1. Age 18 years – 60 years 2. Fasting Blood Glucose (FBG) between 110-125mg/dl or 2-hr Post Oral Glucose Blood Glucose (OGTT) between 140-199mg/dl or both

Exclusion Criteria

1. Patients on any vitamin or mineral supplementation 2.Current use of a weight loss medicine or dietary modification. 3. Alcohol consumption > 20 g/day 4.Lactation, pregnancy or unwillingness to use an effective form of birth control for women of child bearing years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of glycaemic control by Zinc supplementation using the following parameters:<br><br>1.Fasting Blood Glucose <br>2. Post Oral Glucose Blood Glucose <br>3. HbA1C <br>4. Serum Insulin [At baseline, 1, 3, 6 and 12 months]<br>
Secondary Outcome Measures
NameTimeMethod
ipid profile [At baseline, 1, 3, 6 and 12 months]<br>Anthropometric assessment [At baseline, 1, 3, 6 and 12 months]<br>Insulin resistance (using HOMA: Homeostatic Model Assessment of Insulin Resistance) [At baseline, 1, 3, 6 and 12 months ]<br>
© Copyright 2025. All Rights Reserved by MedPath